SEC Form 4 · accession 0001493152-17-002420
HARROW, INC. · HROW
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert J Kammer
Director
Period of report
Mar 9, 2017
Accepted (ET)
Mar 14, 2017 · 5:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001360214
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 9, 2017 | J | 20,000 | $0.00 | D | 1,069,827 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On March 9, 2017, Dr. Kammer, transferred 20,000 shares of Imprimis Pharmaceuticals, Inc.'s common stock to a third party, in connection with a settlement agreement and previously settled lawsuit. As part of the settlement, Dr. Kammer transferred 20,000 shares of common stock and received no consideration.